Previous 10 | Next 10 |
The clinical-stage company TFF Pharmaceuticals (NASDAQ:TFFP) announced safety and pharmacokinetic (PK) results from its Phase 1 study of Niclosamide Inhalation Powder in COVID-19 on Tuesday. The company plans to use its Thin Film Freezing (TFF) technology to target the affected lungs with an ...
Niclosamide Inhalation Powder Well Tolerated with No Serious Adverse Events Across All Subject Cohorts Current Data Suggests Niclosamide Inhalation Powder is a Promising Antiviral Treatment to Combat COVID-19 FORT WORTH, Texas, April 19, 2022 (GLOBE NEWSWIRE) -- TFF Pharma...
Sunshine Biopharma (SBFM) +119% newly designed mRNA molecules prove effective against multidrug resistant cancer cells. System1 (SST) +26%. Recon Technology (RCON) +23%. Aterian (ATER) +13%. Guardforce AI (GFAI) +12% on expanding applications of robotics solutions. Arcus Biosci...
Image source: The Motley Fool. TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) Q4 2021 Earnings Call Mar 24, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TFF Pharmaceuticals, Inc. (TFFP) Q4 2021 Earnings Call Transcript...
TFF Pharmaceuticals, Inc. (TFFP) Q4 2021 Earnings Conference Call March 24, 2022, 04:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President and CEO Dale Christensen - Director of Clinical Development Bill Williams - University of Texas, Austin Kirk Coleman - CFO...
TFF Pharmaceuticals press release (NASDAQ:TFFP): FY GAAP EPS of -$1.25 misses by $0.12. Revenue of $0.09M misses by $0.59M. As of December 31, 2021, TFF Pharmaceuticals reported cash and cash equivalents of $33.8 million. Shares +0.15%. For further details see: TFF P...
Pipeline Advancement Continues with Ongoing Phase 2 Studies for Voriconazole and Tacrolimus Programs Partnership Activity Surrounding Thin Film Freezing Continues to Expand Reflecting the Technology’s Broad Applicability Across Molecule Type and Therapeutic Area A...
The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: TFF Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation
OTCQX:CCHWF, CIH, OTCQX:CWBHF, DRI, FDS, HOOK, OTCQX:JUSHF, KC, MOMO, NEOG, SNX, TFFP, TITN, TMDI For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open
TFF Pharmaceuticals (NASDAQ:TFFP) is trading ~6% higher in the pre-market Thursday after announcing a research agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and The Geneva Foundation, a non-profit within the U.S. military. The Cooperative Research a...
News, Short Squeeze, Breakout and More Instantly...
TFF Pharmaceuticals Inc - Ordinary Shares Company Name:
TFFP Stock Symbol:
NASDAQ Market:
TFF Pharmaceuticals Inc - Ordinary Shares Website:
FORT WORTH, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
FDA Provided Constructive Feedback to Help Guide Next Steps in TFF TAC Clinical Development Company to Provide More Detailed Regulatory Update in 3Q 2024 FORT WORTH, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a ...